{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:43:17Z","timestamp":1789177397937,"version":"build-2803163510"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Viagra\u00ae (sildenafil citrate) has a rapid onset of action for the treatment of erectile dysfunction (ED). However, its duration of action has not been thoroughly investigated. Practical knowledge of the time window available for sexual intercourse would be valuable for couples planning sexual activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We investigated the duration of action of sildenafil in men with ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a double-blind, randomized, placebo-controlled, four-way crossover study of 16 men, mean age of 55\u2003years (range, 36\u201368\u2003years) with ED of no known organic cause. Participants received oral sildenafil (100\u2003mg) or placebo 1, 8, or 12\u2003hours before visual sexual stimulation (VSS). Measurements included the duration of erections of \u2265\u200a60% rigidity, assessed by penile plethysmography (RigiScan\u00ae), and the proportion of sildenafil responders, defined as patients with erections of \u2265\u200a60% rigidity for \u2265\u200a4\u2003minutes and \u2265\u200a50% improvement over erections achieved in their placebo arm. Self-assessed duration of grade 3 (hard enough for penetration) or grade 4 (fully hard) erections was also recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At 1, 8, and 12\u2003hours after dosing with sildenafil, the mean duration of erections with \u2265\u200a60% rigidity was 26, 11, and 8\u2003minutes, respectively, compared with only 3\u2003minutes after placebo dosing (P\u2003&amp;lt;\u20030.05). However, the mean duration of self-assessed erections was 33, 23, and 16\u2003minutes, respectively, compared with 7\u2003minutes after placebo dosing (P\u2003&amp;lt;\u20030.05), and was greater than that assessed by RigiScan. Of the 69% sildenafil responders at 1\u2003hour, 82% responded at 8\u2003hours and 45% responded at 12\u2003hours after sildenafil administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Sildenafil improved objective and self-assessed erectile function in men with ED, and the duration of action of sildenafil was longer than that previously reported. These data suggest that sildenafil may be effective in a significant proportion of men with ED up to 12\u2003hours after being taken.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2004.04026.x","type":"journal-article","created":{"date-parts":[[2004,9,13]],"date-time":"2004-09-13T09:44:00Z","timestamp":1095068640000},"page":"179-184","source":"Crossref","is-referenced-by-count":41,"title":["Duration of Action of Sildenafil Citrate in Men with Erectile Dysfunction"],"prefix":"10.1093","volume":"1","author":[{"given":"Clive","family":"Gingell","sequence":"first","affiliation":[{"name":"Department of Urology, Southmead Hospital , Westbury-on-Trym , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Sultana","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Wulff","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Gepi-Attee","sequence":"additional","affiliation":[{"name":"Department of Urology, Southmead Hospital , Westbury-on-Trym , Bristol , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,9,1]]},"reference":[{"key":"2024032600061934900_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032600061934900_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","article-title":"The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences","volume":"84","author":"Aytac","year":"1999","journal-title":"BJU Int"},{"key":"2024032600061934900_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jacc.2003.07.042","article-title":"Impaired brachial artery endothelium-dependent and \u2013independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease","volume":"43","author":"Kaiser","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024032600061934900_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1464-410X.1996.10220.x","article-title":"Sildenafil, a novel effective oral therapy for male erectile dysfunction","volume":"78","author":"Boolell","year":"1996","journal-title":"Br J Urol"},{"key":"2024032600061934900_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0895-7061(00)01177-8","article-title":"Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy","volume":"14","author":"Kloner","year":"2001","journal-title":"Am J Hypertens"},{"key":"2024032600061934900_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2337\/diacare.26.2.279","article-title":"Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: Results of a randomized controlled trial","volume":"26","author":"Stuckey","year":"2003","journal-title":"Diabetes Care"},{"issue":"2B Suppl","key":"2024032600061934900_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(02)01691-6","article-title":"Depression, antidepressant therapies, and erectile dysfunction: Clinical trials of sildenafil citrate (Viagra\u00ae) in treated and untreated patients with depression","volume":"60","author":"Nurnberg","year":"2002","journal-title":"Urology"},{"key":"2024032600061934900_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0090-4295(02)01606-0","article-title":"Quality of life and erectile dysfunction","volume":"59","author":"Althof","year":"2002","journal-title":"Urology"},{"key":"2024032600061934900_bib9","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1046\/j.0306-5251.2001.00034.x","article-title":"Onset and duration of action of sildenafil citrate for the treatment of erectile dysfunction","volume":"53","author":"Eardley","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"2024032600061934900_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0090-4295(03)00567-3","article-title":"Minimal time to successful intercourse after sildenafil citrate: Results of a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Padma-Nathan","year":"2003","journal-title":"Urology"},{"key":"2024032600061934900_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1464-410X.2003.04684.x","article-title":"The sexual habits of British men and women over 40 years old","volume":"93","author":"Eardley","year":"2004","journal-title":"BJU Int"},{"key":"2024032600061934900_bib12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0022-5347(01)63197-5","article-title":"Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: Reproducibility, evaluation criteria and the effect of sexual intercourse","volume":"159","author":"Hatzichristou","year":"1998","journal-title":"J Urol"},{"key":"2024032600061934900_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-5347(17)32514-4","article-title":"Nocturnal penile tumescence and rigidity in men without complaints of erectile dysfunction using a new quantitative analysis software","volume":"152","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"2024032600061934900_bib14","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.0306-5251.2001.00027.x","article-title":"Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality","volume":"53","author":"Nichols","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"2024032600061934900_bib15","first-page":"00","article-title":"Efficacy of sildenafil citrate at 12 hours after dosing: Re-exploring the therapeutic window","volume":"X","author":"Moncada","year":"2004","journal-title":"Eur Urol"},{"key":"2024032600061934900_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/14656566.4.3.397","article-title":"Long-term use of sildenafil","volume":"4","author":"Carson","year":"2003","journal-title":"Expert Opin Pharmacother"},{"issue":"2B Suppl","key":"2024032600061934900_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-4295(02)01752-1","article-title":"A 4-year update on the safety of sildenafil citrate (Viagra\u00ae)","volume":"60","author":"Padma-Nathan","year":"2002","journal-title":"Urology"},{"key":"2024032600061934900_bib18","first-page":"12","article-title":"Pharmacology of phosphodiesterase 5 inhibitors","volume":"10","author":"Carrier","year":"2003","journal-title":"Can J Urol"},{"key":"2024032600061934900_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1742-1241.2002.tb11296.x","article-title":"Pharmacology of phosphodiesterase 5 inhibitors","volume":"56","author":"Corbin","year":"2002","journal-title":"Int J Clin Pract"},{"key":"2024032600061934900_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s003450000168","article-title":"Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: A RigiScan and pharmacokinetic study","volume":"19","author":"Klotz","year":"2001","journal-title":"World J Urol"},{"issue":"4 Suppl","key":"2024032600061934900_bib21","first-page":"S43","article-title":"The effect of intrinsic and extrinsic factors on the pharmacokinetic properties of tadalafil (IC351)","volume":"13","author":"Patterson","year":"2001","journal-title":"Int J Impot Res"},{"key":"2024032600061934900_bib22","article-title":"Full prescribing information, sildenafil citrate.","author":"VIAGRA\u00ae.","year":"2002"},{"key":"2024032600061934900_bib23","article-title":"Full prescribing information, vardenafil.","author":"LEVITRA\u00ae.","year":"2003"},{"key":"2024032600061934900_bib24","article-title":"Full prescribing information, tadalafil.","author":"CIALIS\u00ae.","year":"2003"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515300783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515300783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/2\/179\/47522047\/jsm_1_2_179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/2\/179\/47522047\/jsm_1_2_179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:03:08Z","timestamp":1711414988000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/1\/2\/179\/6862995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,1]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,9,1]]},"published-print":{"date-parts":[[2004,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2004.04026.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,9]]},"published":{"date-parts":[[2004,9,1]]}}}